Compare GSK plc (GSK) vs Peloton Interactive Inc (PTON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Peloton Interactive Inc — how do they compare? GSK plc trades at $52.79 (market cap $101.34B), while Peloton Interactive Inc trades at $6.41 (market cap $2.74B). The key difference: GSK plc is far larger — about 37× Peloton Interactive Inc's market cap, and GSK plc pays a 3.49% dividend while Peloton Interactive Inc pays none. Which is the better fit depends on your goals.
| GSK | PTON | |
|---|---|---|
Market Cap | $101.34B | $2.74B |
Sector | Health | Consumer Cyclical |
52-Week High | $61.18 | $9.00 |
52-Week Low | $36.20 | $3.71 |
Enterprise Value | $121.95B | $3.34B |
Dividend Yield | 3.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK's stock trades at $51.25, down 1.99% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 17.78% net margin and 36.42% ROE, supported by a consistent earnings beat history. Recent positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline progress. Valuation appears reasonable with a P/E of 13.71 and EV/EBITDA of 9.16.
The outlook balances a solid core business and promising oncology pipeline against a mixed analyst consensus and near-term cash flow pressures. Key opportunities lie in execution of new drug launches and the upcoming CEO strategy update, while risks include clinical trial setbacks, competitive pressures, and integration of potential acquisitions like Nuvalent.
Peloton (PTON) trades at $6.16, up 1.32% with a bullish technical signal from moving averages. The company shows improving fundamentals with positive operating cash flow of $333M in 2025 and projected net income of $23M in 2026. However, revenue continues to decline from $3.6B in 2022 to $2.5B in 2025, while debt-to-asset ratio has worsened to 70.53%. Recent news highlights stabilization efforts including new CFO appointment and S&P SmallCap 600 inclusion.
PTON presents a turnaround story with improving profitability metrics but faces significant challenges from declining revenue and high debt burden. The stock trades below analyst consensus target of $7.50, offering potential upside if execution improves, though subscriber stagnation and competitive pressures remain key risks for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Peloton Interactive Inc
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →
